Miller C C, Villa M A, Sutton J, Lau D, Keyhani K, Estrera A L, Azizzadeh A, Coogan S M, Safi H J
Department of Cardiothoracic and Vascular Surgery, University of Texas Medical School at Houston, Memorial Hermann Heart and Vascular Institute, Houston, TX 77030, USA.
Eur J Vasc Endovasc Surg. 2009 Apr;37(4):388-94. doi: 10.1016/j.ejvs.2008.12.020. Epub 2009 Feb 15.
The intractability of renal dysfunction following thoracic and thoraco-abdominal aortic repair leads us to believe that the accepted mechanisms of renal injury - ischaemia and embolism - are incompletely explanatory. We studied postoperative myoglobinaemia and renal dysfunction following aortic surgery.
Between September 2006 and February 2008, we studied serum myoglobin in 109 patients requiring thoracic/thoraco-abdominal repair for three postoperative days. Forty-two of the 109 (38%) patients were female. The median age was 67 years (range 23-84 years). As we have focussed more attention on renal function, our independent renal consultants have dialysed more aggressively. We divided dialysis into: (1) creatinine indication, (2) non-creatinine indication and (3) no dialysis.
Thirteen of the 109 (12%) patients met creatinine indication for dialysis (>4 mg dl(-1)) and an additional 28 (26%) were dialysed for other reasons. Overall mortality was 12 out of 109 (11%) cases: 11 out of 41 (27%) in dialysed patients and one out of 68 (1.5%) in non-dialysed patients. Mortality did not differ between the indications for dialysis. Predictors of mortality were baseline glomerular filtration rate (GFR), postoperative myoglobin and dialysis. The only predictor of dialysis was postoperative myoglobin.
A strong relationship between postoperative serum myoglobin and renal failure suggests a rhabdomyolysis-like contributing aetiology following thoraco-abdominal aortic repair. We postulate a novel mechanism of renal injury for which mitigation strategies should be developed.
胸主动脉及胸腹主动脉修复术后肾功能障碍的难治性使我们认为,公认的肾损伤机制——缺血和栓塞——并不能完全解释其原因。我们研究了主动脉手术后的术后肌红蛋白尿血症和肾功能障碍。
在2006年9月至2008年2月期间,我们对109例需要进行胸主动脉/胸腹主动脉修复的患者术后三天的血清肌红蛋白进行了研究。109例患者中有42例(38%)为女性。中位年龄为67岁(范围23 - 84岁)。由于我们更加关注肾功能,我们的独立肾脏顾问进行了更积极的透析治疗。我们将透析分为:(1)肌酐指标,(2)非肌酐指标,(3)未进行透析。
109例患者中有13例(12%)符合透析的肌酐指标(>4 mg dl⁻¹),另外28例(26%)因其他原因接受透析。总死亡率为109例中的12例(11%):透析患者中41例有11例(27%)死亡,未透析患者中68例有1例(1.5%)死亡。不同透析指征的死亡率无差异。死亡率的预测因素为基线肾小球滤过率(GFR)、术后肌红蛋白和透析。透析的唯一预测因素是术后肌红蛋白。
术后血清肌红蛋白与肾衰竭之间的密切关系表明,胸腹主动脉修复术后存在类似横纹肌溶解的病因。我们推测了一种新的肾损伤机制,应据此制定缓解策略。